News

Astrazeneca’s Coronavirus Vaccine Shows Positive Results

Written by Yourway | July 30, 2020

Astrazeneca’s coronavirus vaccine shows promise in an early phase clinical trial. The phase one trial involved over 1,000 participants aged 18-55, with reported side effects mild overall. With a comprehensive customer portal perfect for large scale trials, Yourway allows our clients to manage the movement of goods, monitoring critical factors like location, temperature, shock and vibration, and exposure to light, all crucial to maintaining quality in a successful clinical trial.